Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
Lorusso, D, Scambia, G, Amadio, G, di Legge, A, Pietragalla, A, De Vincenzo, R, Masciullo, V, Di Stefano, M, Mangili, G, Citterio, G, Mantori, M, Lambiase, A, Bordignon, CVolume:
107
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.233
Date:
June, 2012
File:
PDF, 343 KB
english, 2012